News Focus
News Focus
icon url

BioRecruiter

08/09/12 10:29 AM

#3814 RE: cobra1964 #3810

I dont thing the delay was labeling but I know for a fact the FDA didnt request any additional info from the trial.
icon url

goodwill4all

08/09/12 10:44 AM

#3818 RE: cobra1964 #3810

I stand corrected on Peds - not part of Aug. PDUFA date.

On labeling negotiations - My question is why did Talon dose first patient post May PDUFA extension and why is the confirmatory study powered for superiority?

Trust me, any drug company with a pending drug under FDA review & pre-approval cannot give specifics. Labeling negotiations is even more that I think is appropriate, but no one besides the FDA & Talon knows what that means. Coould be dose related, indications, post marketing...